Home > Insider Trading > Filing (0000899243-22-028250)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
875320	Vertex Pharmaceuticals Inc / Ma	VRTX	Pharmaceutical Preparations (2834)	043039129

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1643921	N. Sangeeta Bhatia	C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2022-08-08	45	$290.18	5,237	No	4	S	Direct
Common Stock	Disposition	2022-08-08	164	$291.76	5,073	No	4	S	Direct
Common Stock	Disposition	2022-08-08	204	$293.15	4,869	No	4	S	Direct
Common Stock	Disposition	2022-08-08	161	$294.24	4,708	No	4	S	Direct
Common Stock	Disposition	2022-08-08	47	$295.53	4,661	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Footnotes

Transaction made pursuant to Dr. Bhatia's company approved trading plan under Rule 10b5-1.
Dr. Bhatia undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $290.18 (range $290.05 to $290.20).
Open market sales reported on this line occurred at a weighted average price of $291.76 (range $291.59 to $291.91).
Open market sales reported on this line occurred at a weighted average price of $293.15 (range $292.71 to $293.61).
Open market sales reported on this line occurred at a weighted average price of $294.24 (range $293.85 to $294.49).